1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceuticals: Global Group of Eight (G8) Industry Guide

Introduction

The G8 Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2019). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

* Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
* Leading company profiles reveal details of key pharmaceuticals market players’ G8 operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
* Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Highlights

The G8 countries contributed $554.1 billion in 2014 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 3.3% between 2010 and 2014. The G8 countries are expected to reach a value of $684.8 billion in 2019, with a CAGR of 4.3% over the 2014-19 period.
Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $303.9 billion in 2014. This was followed by Japan and Germany, with a value of $85.5 and $37.1 billion, respectively.
The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $390.7 billion in 2016, followed by Japan and Germany with expected values of $102.2 and $44.8 billion, respectively.

Your key questions answered

* What was the size of the G8 pharmaceuticals market by value in 2014?
* What will be the size of the G8 pharmaceuticals market in 2019?
* What factors are affecting the strength of competition in the G8 pharmaceuticals market?
* How has the market performed over the last five years?
* Who are the top competitors in the G8 pharmaceuticals market?

Table Of Contents

Pharmaceuticals: Global Group of Eight (G8) Industry Guide
INTRODUCTION
What is this report about?
Who is the target reader?
How to use this report
Definitions
GROUP OF EIGHT (G8) PHARMACEUTICALS
Industry Outlook
PHARMACEUTICALS IN CANADA
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN FRANCE
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN GERMANY
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN ITALY
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN JAPAN
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN RUSSIA
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN THE UNITED KINGDOM
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
PHARMACEUTICALS IN THE UNITED STATES
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
COMPANY PROFILES
Leading companies
APPENDIX
Methodology
About MarketLine

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes

  • $ 6 995
  • Industry report
  • February 2016
  • by GBI Research

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes Summary The breast cancer pipeline is the largest in the pharmaceutical industry, with 1,050 ...

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 5 750
  • Industry report
  • April 2016
  • by Feedback Business Consulting

This report provides an insight into the Indian Pharmaceutical current market scenario, structure and practices. In depth market scenario includes; - Current market size estimates, including domestic market, ...

Omega 3 PUFA Market: Type (DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid), ALA (Alpha-linoleic acid)) Source (Marine, Plant) Form (Oils, Capsules, Powder) Application (Dietary Supplements, Pharmaceuticals, Infant Foods, F&B)-Forecast(2015-2020)

Omega 3 PUFA Market: Type (DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid), ALA (Alpha-linoleic acid)) Source (Marine, Plant) Form (Oils, Capsules, Powder) Application (Dietary Supplements, Pharmaceuticals, Infant Foods, F&B)-Forecast(2015-2020)

  • $ 5 250
  • Industry report
  • February 2016
  • by Industry ARC

Omega-3 fatty acids are polyunsaturated fatty acids which have potential health benefits and are essential for increasing metabolic rate. Omega-3 PUFA ingredients are used to manufacture products that ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.